跳至主要内容
临床试验/NCT04738994
NCT04738994已完成不适用

Effects of Whey Protein-enriched Nutritional Supplement on Gut Microbiota and Inflammatory Status, in Patients Attending a Cardiac Rehabilitation Program

Fondazione Don Carlo Gnocchi Onlus2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2018年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
2
主要终点
Pro-inflammatory cytokine interleukin 6 (IL-6)

研究概览

简要总结

In this randomized trial the primary outcome is to assess if high doses of whey protein supplement may lower pro-inflammatory interleukin 6 (IL-6).

Hypothesis: Secondary outcomes are to assess if high doses of whey protein supplement may lower pro-inflammatory interleukin 1β (IL-1 β), tumor necrosis factor and C Reactive Protein (CRP); may increase anti-inflammatory interleukin 10 (IL-10) plasma concentrations and may change Gut Microbiota (GM) composition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission for cardiac rehabilitation
  • Signed informed consent

排除标准

  • Patient unable to eat orally
  • Eating disorders
  • Indication to Levodopa therapy
  • Gastrointestinal malignant diseases
  • Known kidney failure
  • Known liver failure
  • Previous antibiotic therapy

结局指标

主要结局

Pro-inflammatory cytokine interleukin 6 (IL-6)

时间窗: Baseline (T0) and day 15 (T1)

Change in IL-6 \[Time Frame: after 15 days (T1) from baseline (T0)\]

次要结局

  • Anti- inflammatory cytokine interleukin 10 (IL-10)(Baseline (T0) and day 15 (T1))
  • Gut Microbiota (GM)(Baseline (T0) and day 15 (T1))
  • C-Reactive Protein (CRP)(Baseline (T0) and day 15 (T1))
  • Pro-inflammatory cytokine interleukin 1beta (IL-1β)(Baseline (T0) and day 15 (T1))
  • Tumor Necrosis Factor (TNF)(Baseline (T0) and day 15 (T1))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验